Characteristics | N = 32 (%) |
---|---|
Median age at treatment (years) | 48 (25–77) |
Cigarette smoking | |
Yes | 1 (3) |
No | 31 (97) |
Cardiopulmonary comorbidities | |
None | 19 (59) |
Hypertension | 7 (22) |
Hyperlipidemia | 2 (6) |
Diabetes mellitus | 4 (3) |
Breast cancer stage | |
I | 9 (28) |
II | 9 (28) |
III | 14 (44) |
Tumor stage | |
T1 | 14 (44) |
T2 | 11 (34) |
T3 | 7 (22) |
Nodal stage | |
0 | 11 (34) |
1 | 9 (28) |
2 | 2 (6) |
3 | 10 (31) |
Breast conservation | |
Yes | 20 (63) |
No | 12 (37) |
Systemic therapy | |
Neoadjuvant chemotherapy | 15 (47) |
Adjuvant chemotherapy | 13 (41) |
Adjuvant trastuzumab | 11 (34) |
Adjuvant endocrine therapy | 9 (28) |
None | 0 (0) |